SCHEMBL25380258

SCHEMBL25380258

O=[N+]([O-])c1ccc(-c2ccc(F)cc2)cc1-c1ccn(Cc2cccnc2)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRIN1 Q05586 6/20 0.43
▸ GRIN2B Q13224 6/20 0.43
▸ MAPT P10636 3/20 0.42
▸ POLB P06746 2/20 0.42
▸ CYP11B1 P15538 2/20 0.42
▸ CYP11B2 P19099 2/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ CCR6 P51684 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ CYP3A4 P08684 3/20 0.38
▸ PKM P14618 1/20 0.38
▸ NPC1 O15118 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30509946 1.00 GRIN1 (0.43) GRIN1GRIN2BMAPTPOLBCYP11B1
SCHEMBL30510003 0.92 CYP11B1 (0.48) MAPTPOLBCYP11B1CYP11B2KDM4E
SCHEMBL25378904 0.92 CYP11B1 (0.48) MAPTPOLBCYP11B1CYP11B2KDM4E
SCHEMBL26192887 0.90 POLB (0.46) GRIN1GRIN2BMAPTPOLBCYP11B1
SCHEMBL26192893 0.90 MAPT (0.42) GRIN1GRIN2BMAPTPOLBCYP11B1
SCHEMBL30510183 0.85 POLB (0.41) MAPTPOLBCYP11B1CYP11B2KDM4E
SCHEMBL25379857 0.85 POLB (0.41) MAPTPOLBCYP11B1CYP11B2KDM4E
SCHEMBL25257139 0.84 HTT (0.44) MAPTPOLBCYP11B1CYP11B2KDM4E
SCHEMBL30509940 0.84 HTT (0.44) MAPTPOLBCYP11B1CYP11B2KDM4E
SCHEMBL25377104 0.83 GRIN2B (0.44) GRIN1GRIN2BMAPTKDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12552772-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD SPRINGWORKS THERAPEUTICS, INC. (US) 2026-02-17 — — US disclosed
US-20250115574-A1 2-PYRAZOLE ANILINES AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD VIB VZW (BE) 2025-04-10 — — US disclosed
US-12030866-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD SPRINGWORKS THERAPEUTICS, INC. (US) 2024-07-09 — — US disclosed
US-12030866-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD SPRINGWORKS THERAPEUTICS, INC. (US) 2024-07-09 — — US disclosed
US-20230278982-A1 2-Pyrazole Anilines and Related Analogs for Inhibiting YAP/TAZ-TEAD KU LEUVEN R&D (BE) 2023-09-07 — — US disclosed
US-20230278982-A1 2-Pyrazole Anilines and Related Analogs for Inhibiting YAP/TAZ-TEAD KU LEUVEN R&D (BE) 2023-09-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12552772-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD YAP1, TEAD3, TEAD2 GRIN1 4512/4885GRIN2B 4652/4885MAPT 1955/4885
US-20230278982-A1 2-Pyrazole Anilines and Related Analogs for Inhibiting YAP/TAZ-TEAD YAP1, TEAD3, TEAD2 GRIN1 4578/4885GRIN2B 4635/4885MAPT 2994/4885
US-12030866-B2 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD YAP1, TEAD3, TEAD2 GRIN1 4578/4885GRIN2B 4635/4885MAPT 2994/4885
US-20250115574-A1 2-PYRAZOLE ANILINES AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD YAP1, TEAD3, TEAD2 GRIN1 4578/4885GRIN2B 4635/4885MAPT 2994/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback